有证据表明,饮食管理胺素不耐受症
Kirsten Jackson1, Wendy Busse2, Patricia Gálvez-Martín3
1The IBS Dietitian.
International journal of molecular sciences
|September 27, 2025
概括
胰岛素不耐受 (HIT) 影响了许多人,导致症状是由于由二胺氧化酶 (DAO) 破坏胰岛素的破坏. 饮食变化和DAO补充剂显示出对管理HIT症状的承诺.
科学领域:
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
- 营养科学 营养科学
背景情况:
- 自我报告的食物不耐受会影响15-20%的人口.
- 基因组胺不耐受性 (HIT) 的特点是由于饮食中的基因组胺摄入量与身体降解基因组胺的能力之间的不平衡引起的症状.
- HIT通常与二胺氧化酶 (DAO) 的活性降低有关,二胺氧化酶是负责基因组胺分解的主要酶.
研究的目的:
- 探索诊断组胺素不耐受症的挑战.
- 审查目前用于管理HIT的治疗策略,重点关注饮食干预措施.
- 评估胺氧化酶 (DAO) 补充剂在HIT管理中的潜在作用和有效性.
主要方法:
- 诊断HIT依赖于临床评估和对饮食修改的反应,因为缺乏经过验证的生物标志物.
- 治疗策略主要涉及饮食管理,包括限制高组胺食物.
- 研究了胺氧化酶 (DAO) 补充剂的潜在益处,考虑了影响其活性的因素.
主要成果:
- 诊断HIT仍然具有挑战性,主要依赖于临床评估和饮食反应.
- 饮食管理虽然是治疗的核心,但对患者来说存在困难.
- 补充DAO可能在缓解HIT的临床表现方面发挥有益作用,尽管临床证据有限.
结论:
- 基因组胺不耐症是一种复杂的疾病,受饮食中的基因组胺和个体基因组胺降解能力的影响.
- 目前的管理重点是低组胺饮食,DAO补充剂显示出潜力,但需要进一步的临床验证.
- 需要进一步的研究来建立明确的诊断标记,并优化对HIT的治疗干预措施.
相关概念视频
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
944
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
944
Gastritis III: Clinical Manifestations and Management
1.2K
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
1.2K
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
643
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
643
Gastroesophageal Reflux Disease II: Clinical Features and Management
698
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
698
Peptic Ulcer Disease IV: Management
436
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
436
Atherosclerosis III: Management
321
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
321


